BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19213072)

  • 1. Bortezomib reverses a post-translational mechanism of tumorigenesis for patched1 haploinsufficiency in medulloblastoma.
    Taniguchi E; Cho MJ; Arenkiel BR; Hansen MS; Rivera OJ; McCleish AT; Qualman SJ; Guttridge DC; Scott MP; Capecchi MR; Keller C
    Pediatr Blood Cancer; 2009 Aug; 53(2):136-44. PubMed ID: 19213072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-hit model for progression of medulloblastoma preneoplasia in Patched heterozygous mice.
    Pazzaglia S; Tanori M; Mancuso M; Gessi M; Pasquali E; Leonardi S; Oliva MA; Rebessi S; Di Majo V; Covelli V; Giangaspero F; Saran A
    Oncogene; 2006 Sep; 25(40):5575-80. PubMed ID: 16636673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two tumor suppressors, p27Kip1 and patched-1, collaborate to prevent medulloblastoma.
    Ayrault O; Zindy F; Rehg J; Sherr CJ; Roussel MF
    Mol Cancer Res; 2009 Jan; 7(1):33-40. PubMed ID: 19147535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional evaluation of therapeutic response for a mouse model of medulloblastoma.
    Samano AK; Ohshima-Hosoyama S; Whitney TG; Prajapati SI; Kilcoyne A; Taniguchi E; Morgan WW; Nelon LD; Lin AL; Togao O; Jung I; Rubin BP; Nowak BM; Duong TQ; Keller C
    Transgenic Res; 2010 Oct; 19(5):829-40. PubMed ID: 20107895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patched1 deletion increases N-Myc protein stability as a mechanism of medulloblastoma initiation and progression.
    Thomas WD; Chen J; Gao YR; Cheung B; Koach J; Sekyere E; Norris MD; Haber M; Ellis T; Wainwright B; Marshall GM
    Oncogene; 2009 Apr; 28(13):1605-15. PubMed ID: 19234491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mouse model for medulloblastoma and basal cell nevus syndrome.
    Corcoran RB; Scott MP
    J Neurooncol; 2001 Jul; 53(3):307-18. PubMed ID: 11718263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gli1 is important for medulloblastoma formation in Ptc1+/- mice.
    Kimura H; Stephen D; Joyner A; Curran T
    Oncogene; 2005 Jun; 24(25):4026-36. PubMed ID: 15806168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of medulloblastoma tumorigenesis by the antiproliferative and pro-differentiative gene PC3.
    Farioli-Vecchioli S; Tanori M; Micheli L; Mancuso M; Leonardi L; Saran A; Ciotti MT; Ferretti E; Gulino A; Pazzaglia S; Tirone F
    FASEB J; 2007 Jul; 21(9):2215-25. PubMed ID: 17371797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor 2 is required for progression to advanced medulloblastoma in patched1 heterozygous mice.
    Corcoran RB; Bachar Raveh T; Barakat MT; Lee EY; Scott MP
    Cancer Res; 2008 Nov; 68(21):8788-95. PubMed ID: 18974121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposite modifying effects of HR and NHEJ deficiency on cancer risk in Ptc1 heterozygous mouse cerebellum.
    Tanori M; Pasquali E; Leonardi S; Giardullo P; Di Majo V; Taccioli G; Essers J; Kanaar R; Mullenders LH; Atkinson MJ; Mancuso M; Saran A; Pazzaglia S
    Oncogene; 2011 Nov; 30(47):4740-9. PubMed ID: 21602895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of the PACAP gene promotes medulloblastoma in ptc1 mutant mice.
    Lelievre V; Seksenyan A; Nobuta H; Yong WH; Chhith S; Niewiadomski P; Cohen JR; Dong H; Flores A; Liau LM; Kornblum HI; Scott MP; Waschek JA
    Dev Biol; 2008 Jan; 313(1):359-70. PubMed ID: 18036580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ptc1 heterozygous knockout mice as a model of multi-organ tumorigenesis.
    Pazzaglia S
    Cancer Lett; 2006 Mar; 234(2):124-34. PubMed ID: 15925443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tis21 knock-out enhances the frequency of medulloblastoma in Patched1 heterozygous mice by inhibiting the Cxcl3-dependent migration of cerebellar neurons.
    Farioli-Vecchioli S; CinĂ  I; Ceccarelli M; Micheli L; Leonardi L; Ciotti MT; De Bardi M; Di Rocco C; Pallini R; Cavallaro S; Tirone F
    J Neurosci; 2012 Oct; 32(44):15547-64. PubMed ID: 23115191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bortezomib stabilizes NOXA and triggers ROS-associated apoptosis in medulloblastoma.
    Ohshima-Hosoyama S; Davare MA; Hosoyama T; Nelon LD; Keller C
    J Neurooncol; 2011 Dec; 105(3):475-83. PubMed ID: 21633906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RBP-J is not required for granule neuron progenitor development and medulloblastoma initiated by Hedgehog pathway activation in the external germinal layer.
    Julian E; Hallahan AR; Wainwright BJ
    Neural Dev; 2010 Oct; 5():27. PubMed ID: 20950430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental and oncogenic effects of insulin-like growth factor-I in Ptc1+/- mouse cerebellum.
    Tanori M; Santone M; Mancuso M; Pasquali E; Leonardi S; Di Majo V; Rebessi S; Saran A; Pazzaglia S
    Mol Cancer; 2010 Mar; 9():53. PubMed ID: 20214787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical, heritable and age-related factors as modifiers of radiation cancer risk in patched heterozygous mice.
    Pazzaglia S; Pasquali E; Tanori M; Mancuso M; Leonardi S; di Majo V; Rebessi S; Saran A
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1203-10. PubMed ID: 19201105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic alterations in mouse medulloblastomas and generation of tumors de novo from primary cerebellar granule neuron precursors.
    Zindy F; Uziel T; Ayrault O; Calabrese C; Valentine M; Rehg JE; Gilbertson RJ; Sherr CJ; Roussel MF
    Cancer Res; 2007 Mar; 67(6):2676-84. PubMed ID: 17363588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canonical Notch signaling is not required for the growth of Hedgehog pathway-induced medulloblastoma.
    Julian E; Dave RK; Robson JP; Hallahan AR; Wainwright BJ
    Oncogene; 2010 Jun; 29(24):3465-76. PubMed ID: 20418906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medulloblastomas derived from Cxcr6 mutant mice respond to treatment with a smoothened inhibitor.
    Sasai K; Romer JT; Kimura H; Eberhart DE; Rice DS; Curran T
    Cancer Res; 2007 Apr; 67(8):3871-7. PubMed ID: 17413002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.